USTEKINUMAB-HMNY

1 reported adverse events

Drug classes: Interleukin-12 Antagonist [EPC] Interleukin-23 Antagonist [EPC]

These side effects are most commonly reported by patients taking USTEKINUMAB-HMNY:

# Side effect Count
0 BLOOD GLUCOSE INCREASED 1
1 DRUG INEFFECTIVE 1
2 DYSPNOEA 1
3 HEPATIC CIRRHOSIS 1
4 NASOPHARYNGITIS 1
5 PAIN 1
6 PAIN IN EXTREMITY 1
7 PERIPHERAL SWELLING 1
8 POLYP 1
9 PSORIATIC ARTHROPATHY 1
See all common reactions for USTEKINUMAB-HMNY

USTEKINUMAB-HMNY is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 POLYP 1 0.0002
1 SKIN REACTION 1 0.0001
2 HEPATIC CIRRHOSIS 1 0.0001
3 PSORIATIC ARTHROPATHY 1 0.0000
4 THERAPY INTERRUPTED 1 0.0000
5 PERIPHERAL SWELLING 1 0.0000
6 TREMOR 1 0.0000
7 NASOPHARYNGITIS 1 0.0000
8 BLOOD GLUCOSE INCREASED 1 0.0000
9 PAIN IN EXTREMITY 1 0.0000
See all enriched reactions for USTEKINUMAB-HMNY